Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.000001 0 (0%) Market Cap: - Enterprise Value: -17.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Infinity Pharmaceuticals Inc to Discuss Clinical Data from MARIO-275 - Conference Call Transcript

Feb 11, 2021 / 12:30PM GMT
Release Date Price: $4.47 (+13.16%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Infinity Pharmaceuticals ASCO Genitourinary Cancers Symposium Call.

(Operator Instructions)

Please be advised that today's conference is being recorded. (Operator Instructions)

I would now hand the conference over to your host today, Jayne Kauffman. Please go ahead.

Jayne Kauffman
Infinity Pharmaceuticals, Inc. - Senior Executive Coordinator

Good morning, everyone, and welcome to today's call where we will review data from MARIO-275, which was presented today during the ASCO Genitourinary Cancer Symposium, or ASCO GU.

Participants on today's call are Adelene Perkins, Chief Executive Officer; and Dr. Brian Schwartz, Consulting Chief Physician from Infinity Pharmaceuticals.

During this call, we may make forward-looking statements about our future expectations and plans, including clinical development objectives, the therapeutic potential of our product candidates, our strategic plans and financial projections. Our actual results may differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot